Henderson Mary Elizabeth's Form 4 filing
Jazz Pharmaceuticals plc (JAZZ) · filed Sep 10, 2026
- Accession no.
- 0001989533-26-000019
- Filed
- Sep 10, 2026, 4:28 PM ET
- Trade date
- Sep 8, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Henderson Mary ElizabethCIK 0001989533 | Officer (SVP, Technical Operations) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Ordinary Shares | FTax withholdingDisposed | −1,412 | $243.03 | −$343,158.22 | 23,830 | Direct | |
| Sep 8, 2026 | Ordinary Shares | FTax withholdingDisposed | −15 | $241.20 | −$3,618 | 23,815 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.